NCT03179904 2026-02-24TVB-2640 and Trastuzumab With Paclitaxel or Endocrine Therapy for Treatment of HER2 Positive Metastatic Breast CancerMayo ClinicPhase 2 Active not recruiting17 enrolled 10 charts
NCT07407920 2026-02-12Ph2 Study for Optimization of Adjunct Systemic Therapy in HER2+ Patients, MolecularPCR TrialM.D. Anderson Cancer CenterPhase 2 Active not recruiting120 enrolled